Compliance in the treatment of vaginal dysbiosis

Abstract

The high recurrence rate, despite antimicrobial therapy, led to the search for alternative therapies that could be prescribed in conjunction with drugs already used or as monotherapy. Therefore, in cases of dysbiosis, logical and physiological, according to the regulatory influence on the microflora and the mechanism of therapeutic activity, is the appointment of probiotics. The article provides case studies of the use of probiotic Vagilak.

Keywords

• vaginal biocenosis
• bacterial vaginosis
• first oral probiotic
• l. rhamnosus gr-1® and l. reuteri rc-14®